Chronic Kidney Disease(CKD): Clinical Trials

1 trial for Chronic Kidney Disease(CKD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Chronic Kidney Disease(CKD): new trials by email Literature Review of Chronic Kidney Disease(CKD) trials Research Report on Chronic Kidney Disease(CKD)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT
Finerenone (BAY 94-8862), Empagliflozin 10 mg - Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC)
Phase 2TerminatedJinling Hospital, China102025-01-012025-12-11

Narrower conditions

Carcinoma, Renal Cell (1)  ·  Kidney Neoplasms (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)

Interventions

empagliflozin (1)  ·  finerenone (1)

Sponsors

Jinling Hospital, China (1)

Countries

China (1)